The latest price target for Astera Labs (NASDAQ:ALAB) was reported by Morgan Stanley on January 21, 2025. The analyst firm set a price target for $142.00 expecting ALAB to rise to within 12 months (a possible 23.19% upside). 38 analyst firms have reported ratings in the last year.

The latest analyst rating for Astera Labs (NASDAQ:ALAB) was provided by Morgan Stanley, and Astera Labs downgraded their equal-weight rating.

The last upgrade for Astera Labs Inc happened on September 4, 2024 when Morgan Stanley raised their price target to $55. Morgan Stanley previously had an equal-weight for Astera Labs Inc.

The last downgrade for Astera Labs Inc happened on January 21, 2025 when Morgan Stanley changed their price target from $142 to $142 for Astera Labs Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Astera Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Astera Labs was filed on January 21, 2025 so you should expect the next rating to be made available sometime around January 21, 2026.

While ratings are subjective and will change, the latest Astera Labs (ALAB) rating was a downgraded with a price target of $142.00 to $142.00. The current price Astera Labs (ALAB) is trading at is $115.27, which is out of the analyst’s predicted range.